# E-DRUG: siting policies for retail/community pharmacies? **URL:** \ **Category:** e-drug\ **Created:** [April 22, 1998, 8:52am UTC](https://talk.edrugplus.org/t/e-drug-siting-policies-for-retail-community-pharmacies/2491 "1998-04-22T08:52:07Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Dr\_Wilbert\_Bannenber](https://avatars.discourse-cdn.com/v4/letter/d/49beb7/32.png) [@Dr\_Wilbert\_Bannenber](https://talk.edrugplus.org/u/Dr_Wilbert_Bannenber)\ **Post date:** [April 22, 1998, 8:52am UTC](https://talk.edrugplus.org/t/e-drug-siting-policies-for-retail-community-pharmacies/2491/1 "1998-04-22T08:52:07Z")
E-drug: siting policies for retail/community pharmacies? ------------------------------------------------------------------- Can E-druggers help whether, and if so, how pharmacies are sited in their countries in the interest of public health? Or, in other words, do countries have active policies to close certain areas for new pharmacies, or to promote the opening up of pharmacies in underserved areas? Could E-druggers submit summaries whether such policies exist in their countries, and if so, what criteria, methods and legislative measures are used? And how effective are these measures? Thanks in advance, Wilbert Bannenberg Wilbert Bannenberg, SADAP Coordinator Hallmark 938, P/Bag X 828, Pretoria 0001, South Africa Tel work +27-12-3120374/5 Fax +27-12-3244525 Cellphone +27-82-5756249 Email WilbertBannenberg@compuserve.com or bannew@hltrsa.pwv.gov.za -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.